Edge Wealth Management’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
BCM
JC
AG
WS
Edge Wealth Management's MTCR Position: Q1 2023 in Review
Edge Wealth Management sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 11,000 shares — an estimated $4.76K sold.
Edge Wealth Management first reported a position in MTCR in Q1 2021 and held it in 8 quarters. The position peaked at $40K in Q2 2021. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.
- Edge Wealth Management reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Edge Wealth Management sold 11,000 Metacrine, Inc. Common Stock shares in Q1 2023, an estimated $4.76K.
- Edge Wealth Management first reported a position in Metacrine, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
- Edge Wealth Management's Metacrine, Inc. Common Stock position peaked at $40K in Q2 2021.
- 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.
Based on Edge Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.